Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IRS Rule On Flex-Spending Accounts A Boon For Chronic-Use OTCs, Switches

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough's Claritin and Procter & Gamble's Prilosec OTC are likely to be major beneficiaries of an IRS ruling that nonprescription drugs can be covered by employee health flexible spending arrangements

You may also be interested in...



Visa, Finpago Payment Systems Help Health Account Customers Buy OTCs

Purchasing eligible OTC drugs with health account funds will be easier under systems being developed by payment firms, benefit account providers and automated payment technology companies

Visa, Finpago Payment Systems Help Health Account Customers Buy OTCs

Purchasing eligible OTC drugs with health account funds will be easier under systems being developed by payment firms, benefit account providers and automated payment technology companies

Visa, Finpago Payment Systems Help Health Account Customers Buy OTCs

Purchasing eligible OTC drugs with health account funds will be easier under systems being developed by payment firms, benefit account providers and automated payment technology companies

Related Content

Topics

UsernamePublicRestriction

Register

LL1129367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel